Studies of RNA-binding proteins (RBPs) have demonstrated that their dysregulation plays a key role in altering RNA metabolism in various malignant tumors, and that they are considered to be attractive targets for the occurrence and aggressiveness of PAAD [39,40]. The gene discussed is PTBP1; the disease is pancreatic adenocarcinoma.